Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Interest of EMDR Schizophrenic Disorders

View source ↗

Summary

A clinical trial evaluating EMDR for schizophrenia sponsored by Hôpital NOVO has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hôpital NOVO | Conditions: Schizophrenic Disorders | Status: TERMINATED